EUVIMEDSkopri EUVIMED
Crossref

Using New Peak Detection to Solve Sequence Variants Analysis Challenges in Bioprocess Development

Ben Niu, Yali Lu, Xiaoyu Chen, Wei Xu iD

Journal of the American Society for Mass Spectrometry · 2023

DOI: 10.1021/jasms.2c00292 ↗

At a glance

Journal article in Journal of the American Society for Mass Spectrometry, 2023. Written by Ben Niu and 3 co-authors. Institution: Analytical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland20878United States. Major MEDLINE topics: Tandem Mass Spectrometry, Protein Processing, Post-Translational. Cited 10 times so far (Crossref); 23 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Recombinant therapeutic proteins have become the major class of drugs to treat various human diseases in recent years. Low levels of protein sequence variants (SVs) have been reported to be present in recombinant therapeutic proteins. The consequences of potential unwanted immune response from SVs of recombinant therapeutic proteins have increasingly drawn attention from regulatory authorities and the biopharmaceutical industry. It is highly desirable to detect low-level SVs during clone selection and early process development as part of the control strategy. Peptide mapping with LC-MS/MS analysis has been applied as a powerful tool to characterize post-translation modifications of therapeutic proteins. Despite the recent advancements in mass spectrometry hardware and software, it is still quite challenging and time-consuming to detect and identify low-level SVs. In this study, we present an optimized approach using new peak detection to detect and identify low level SVs with high confidence and high speed. The new approach makes sequence variants analysis by LC-MS/MS broadly applicable and practical in bioprocess development of therapeutic proteins.

Subjects

MeSH terms (MEDLINE)

Tandem Mass SpectrometryProtein Processing, Post-TranslationalHumansChromatography, LiquidPeptide MappingAmino Acid SequenceRecombinant Proteins

Substances

Recombinant Proteins

Authors and institutions

  • Analytical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland20878United States.

ORCID profiles: Wei Xu

Cite

APA

Niu, B., Lu, Y., Chen, X., & Xu, W. (2023). Using New Peak Detection to Solve Sequence Variants Analysis Challenges in Bioprocess Development. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.2c00292

Vancouver

Niu B, Lu Y, Chen X, Xu W. Using New Peak Detection to Solve Sequence Variants Analysis Challenges in Bioprocess Development. Journal of the American Society for Mass Spectrometry. 2023. doi:10.1021/jasms.2c00292

BibTeX
@article{Niu2023,
  author = {Niu, Ben and Lu, Yali and Chen, Xiaoyu and Xu, Wei},
  title = {Using New Peak Detection to Solve Sequence Variants Analysis Challenges in Bioprocess Development},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2023},
  doi = {10.1021/jasms.2c00292}
}
Start for free →